HomeNDC LookupRxCUI directory › RxCUI 1657151

0.5 ML sumatriptan 12 MG/ML Auto-Injector — RxCUI 1657151

RxNorm drug concept · Semantic clinical drug
RxCUI 1657151 Semantic clinical drug · SCD ● Current RxNorm concept 12 FDA products 18 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1657151
Official name0.5 ML sumatriptan 12 MG/ML Auto-Injector
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assumatriptan (as sumatriptan succinate) 6 MG per 0.5 ML Auto-Injector; SUMAtriptan 6 MG in 0.5 ML Auto-Injector
FDA products mapped12
Package NDCs mapped18
Reported Medicaid activity (SDUD)27,753 prescriptions · 45 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sumatriptan: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Sumatriptan is specifically for migraine headaches — it's not a general pain reliever like ibuprofen. It's designed to stop a migraine attack once it's already started, with or wit...
  • What exactly is sumatriptan for? Will it work on any headache?
  • You don't need to wait until it's unbearable. Taking sumatriptan at the first sign of a migraine is generally the right move — don't wait it out. That said, it is meant for confirm...
  • When should I take sumatriptan — do I have to wait until the headache is severe?
📖 Read our full Sumatriptan guide →

🕸️ Concept Web — How 0.5 ML sumatriptan 12 MG/ML Auto-Injector Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 0.5 ML sumatriptan 12 MG/ML Auto-Injector RxCUI 1657151

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Sumatriptan 37418
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sumatriptan Auto-Injector 1657150
    • Sumatriptan Injectable Product 1163610
    • Auto-Injector 1649570
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Sumatriptan 12 MG/ML 330516

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sumatriptan 12 MG/ML SCDC · 330516
  • Sumatriptan Auto-Injector SCDF · 1657150
  • Sumatriptan Injectable Product SCDG · 1163610

📦 FDA Products & Package NDCs

12 products · 18 package NDCs
18 package NDCs map to RxCUI 1657151 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
43598-0768-23 2 SYRINGE in 1 CARTON (43598-768-23) / .5 mL in 1 SYRINGE (... Sumatriptan Succinate Dr. Reddys Laboratories Inc., 2023-04-20
46708-0656-01 2 SYRINGE in 1 CARTON (46708-656-01) / .5 mL in 1 SYRINGE SUMATRIPTAN SUCCINATE Alembic Pharmaceuticals Limited 2025-11-06
46708-0656-05 1 SYRINGE in 1 CARTON (46708-656-05) / .5 mL in 1 SYRINGE SUMATRIPTAN SUCCINATE Alembic Pharmaceuticals Limited 2025-11-06
46708-0657-01 2 SYRINGE in 1 CARTON (46708-657-01) / .5 mL in 1 SYRINGE SUMATRIPTAN SUCCINATE Alembic Pharmaceuticals Limited 2025-11-06
46708-0657-05 1 SYRINGE in 1 CARTON (46708-657-05) / .5 mL in 1 SYRINGE SUMATRIPTAN SUCCINATE Alembic Pharmaceuticals Limited 2025-11-06
47335-0276-40 1 SYRINGE in 1 PACKAGE (47335-276-40) / .5 mL in 1 SYRINGE Sumatriptan Succinate Sun Pharmaceutical Industries, Inc. 2025-08-20
47335-0276-41 2 SYRINGE in 1 PACKAGE (47335-276-41) / .5 mL in 1 SYRINGE Sumatriptan Succinate Sun Pharmaceutical Industries, Inc. 2025-08-20
51407-0673-02 2 SYRINGE in 1 CARTON (51407-673-02) / .5 mL in 1 SYRINGE (... SUMATRIPTAN Golden State Medical Supply, Inc. 2026-02-20
55111-0693-12 2 SYRINGE in 1 CARTON (55111-693-12) / .5 mL in 1 SYRINGE (... Sumatriptan Succinate Dr. Reddy's Laboratories Limited 2014-02-24
62332-0656-01 2 SYRINGE in 1 CARTON (62332-656-01) / .5 mL in 1 SYRINGE SUMATRIPTAN SUCCINATE Alembic Pharmaceuticals Inc. 2025-11-06
62332-0656-05 1 SYRINGE in 1 CARTON (62332-656-05) / .5 mL in 1 SYRINGE SUMATRIPTAN SUCCINATE Alembic Pharmaceuticals Inc. 2025-11-06
62332-0657-01 2 SYRINGE in 1 CARTON (62332-657-01) / .5 mL in 1 SYRINGE SUMATRIPTAN SUCCINATE Alembic Pharmaceuticals Inc. 2025-11-06
62332-0657-05 1 SYRINGE in 1 CARTON (62332-657-05) / .5 mL in 1 SYRINGE SUMATRIPTAN SUCCINATE Alembic Pharmaceuticals Inc. 2025-11-06
64380-0740-01 1 SYRINGE in 1 CARTON (64380-740-01) / .5 mL in 1 SYRINGE SUMATRIPTAN Strides Pharma Science Limited 2026-03-16
64380-0740-02 2 SYRINGE in 1 CARTON (64380-740-02) / .5 mL in 1 SYRINGE SUMATRIPTAN Strides Pharma Science Limited 2026-03-16
72603-0141-02 2 SYRINGE in 1 CARTON (72603-141-02) / .5 mL in 1 SYRINGE (... Sumatriptan Succinate NorthStar Rx LLC 2023-06-13
83270-0151-07 2 SYRINGE in 1 CARTON (83270-151-07) / .5 mL in 1 SYRINGE sumatriptan ONESOURCE SPECIALTY PHARMA LIMITED 2026-02-02
83270-0152-07 2 SYRINGE in 1 CARTON (83270-152-07) / .5 mL in 1 SYRINGE sumatriptan ONESOURCE SPECIALTY PHARMA LIMITED 2026-02-02
Observed labelers: Alembic Pharmaceuticals Inc. (4) · Alembic Pharmaceuticals Limited (4) · ONESOURCE SPECIALTY PHARMA LIMITED (2) · Strides Pharma Science Limited (2) · Sun Pharmaceutical Industries, Inc. (2) · Dr. Reddy's Laboratories Limited (1) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.